Vascular anomaly Flashcards
4 big vascular tumors
infantile hemagioma
congenital hemagioma
Kaposiform hemangioendothelioma (KHE)
Angiosarcoma
compare infantile and congenital hemangioma
infantile: not present at birth, involutes by 3-5y, no coagulopathy, GLUT-1 positive, propranolol
Congenital: present at birth, involutes by 18 mo, transient coagulopathy, GLU-1 neg, no therapy
angiosarcoma features
aggressive
20% GLUT-1 positive
directed therapy
Kaposiform Hemangioendothelioma
newborn
rapid size increase
Kasabach Merritt phenomenon
Tx: sirolimus, VCR, CS
malignant vascular tumors
Epithelioid hemangioendothelioma
angiosarcoma
locally aggressive vascular tumors
kaposiform hemangioendothelioma
retiform hemangioentothelioma
papilary intralymphatic angioendothelioma
Kaposi sarcoma
Benign vascular tumors
infantile/congenital hemangioma
tufted angioma
spindle cell hemangioma
pyogenic granuloma
PHACES syndrome acronym and sites
posterior fossa
hemangioma
arterial (CNS)
cardiac anom (coarc)
eye
sternal
multiple cutaneous hemangiomas: >5 are associated with internal hemangiomas
liver hemangiomas
- focal usually congenital
- multifocal usually infantile
Infantile hemangioma timeline
not present at birth
proliferate 4-6mo
stability
involute by 3-5y
infantile hemangioma US findings
well defined mass
high flow vessel during proliferative phase
low resistive arterial flow
infantile hemangioma tx and s/e
propranolol
- sleep change, irritability, GI, hypotension
- contraind: neonate <4wo, reactive airway disease, AV block, hypoglycemia
Epithelioid hemangioendothelioma features, path, tx
liver, bone, soft tissue, skin
WWTR1-CAMTA1 gene fusion
observe, resect, sirolimus, MEK inhibitor
Kasabach Merritt Syndrome features, what tumors, tx
consumptive coagulopathy
severe thrombocytopenia
+- MAHA
seen in kaposiform hemangioendothelioma, tufted angioma
sirolimus
CS
VCR
what is localized intravascular coagulopathy
venous malformation
high D dimer, low fibrinogen, low/N plt
lymphatic anomalies somatic mutations
PIK3CA
BRAF